Malvern, PA Breaking News Headlines Today

News about Malvern, Pennsylvania

Stay current with all the latest and breaking news about Malvern, Pennsylvania, compare headlines and perspectives between news sources on stories happening today. In total, 68 stories have been published about Malvern, Pennsylvania which Ground News has aggregated in the past 3 months.

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Malvern, Pennsylvania News

Malvern, Pennsylvania · Malvern

Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants

100% Center coverage: 2 sources

MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it has entered into a securities purchase agreement with Janus Henderson…See the Story

Malvern, Pennsylvania · Malvern

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

100% Center coverage: 1 sources

MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA…See the Story

Malvern, Pennsylvania · Malvern

Mergers and Acquisitions (M&A): Pinnaql, Inc. Acquires Validation & Engineering Group, Inc.

Pinnaql, Inc. has announced the acquisition of Validation & Engineering Group, Inc.. According to the company announcement Pinnaql, Inc., a LSOMS Holdings, LP company and a portfolio company of 3 Boomerang Capital, LP, is a provider of quality, regulatory, and operational excellence consulting services to biopharmaceutical, medical device, and CDMO companies globally. The company’s mission is to deliver expert-driven, compliant solutions that em…See the Story

Mergers and Acquisitions (M&A): Pinnaql, Inc. Acquires Validation & Engineering Group, Inc.

Ocugen Gains EMA Backing for Single Pivotal Trial to Support Stargardt Disease Gene Therapy Approval

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has received a key regulatory boost in its bid to bring a gene therapy for Stargardt disease to market, with the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) agreeing that a single, U.S.-based Phase 2/3 trial could support a Marketing Authorization Application in the EU. The EMA opinion follows encouraging Phase 1 results for OCU410ST, which demonstrated a 48% slower …Malvern, Pennsylvania · Malvern Read Article

Annovis Bio Advances Alzheimer’s Phase 3 Trial, Strengthens IP Portfolio

MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) reported progress on its pivotal Phase 3 trial in early Alzheimer’s disease while posting improved second-quarter financial results and expanding its intellectual property protections. The company now has 76 U.S. clinical sites secured for the trial, with 46 actively enrolling and the remainder expected to begin soon. To date, more than 400 patients have been screened, with 38 receiving buntanetap or …Malvern, Pennsylvania · Malvern Read Article

2X Earns Fifth Inc. 5000 Ranking, Citing Rapid Growth in B2B Marketing Transformation

MALVERN, PA — Marketing services firm 2X has been ranked No. 1,084 on the 2025 Inc. 5000 list, marking its fifth appearance on the annual roster of America’s fastest-growing private companies. The recognition places 2X among an elite group of entrepreneurial businesses driving growth in a challenging economic climate. Founded in 2017, 2X specializes in helping B2B organizations scale marketing and revenue operations without increasing overhead. …Malvern, Pennsylvania · Malvern Read Article

Vishay Precision Group to Present at Two Upcoming Investor Conferences

MALVERN, PA — Vishay Precision Group, Inc. (NYSE: VPG) will share corporate updates at two investor events later this summer. The company is scheduled to present at the 16th Annual Midwest IDEAS Conference on August 27, 2025, at the InterContinental Chicago Magnificent Mile, with remarks beginning at 4:30 p.m. ET. VPG will also participate in the Jefferies Industrials Conference on September 3, 2025, at the Westin New York at Times Square, start…Malvern, Pennsylvania · Malvern Read Article

TELA Bio Posts Double-Digit Revenue Growth, Expands Product Reach in Q2

MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) reported a strong second quarter for 2025, delivering $20.2 million in revenue, up 26% from the same period last year and 9% from the previous quarter. The growth was driven by higher demand for its OviTex® and OviTex PRS Reinforced Tissue Matrix products, which saw revenue gains of approximately 12% and 53% year-over-year, respectively. The company also marked a significant milestone with the European…Malvern, Pennsylvania · Malvern Read Article

Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to ...

100% Center coverage: 1 sources

MALVERN, Pa., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the…Malvern, Pennsylvania · Malvern See the Story

Annovis Bio Secures Full Patent Protection for New Crystal Form of Alzheimer’s Drug Buntanetap

MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced the successful transfer and rewrite of all its intellectual property protections to cover a newly developed crystalline form of its lead drug candidate, buntanetap. The move solidifies patent coverage for both the original and crystal versions of the compound through 2046. The company originally built its IP portfolio around a semi-crystalline form of buntanetap, targeting chronic neurodegen…Malvern, Pennsylvania · Malvern Read Article

Neuronetics Issues Inducement Equity Awards to New Hires

MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has granted equity awards to six recently hired employees as inducements to join the company. The grants, consisting of restricted stock units (RSUs), were approved by the company’s Compensation Committee under NASDAQ Listing Rule 5635(c)(4). The awards fall under Neuronetics’ 2020 Inducement Incentive Plan and are subject to time-based vesting tied to continued employment. Among the recipients, Jay…Malvern, Pennsylvania · Malvern Read Article

Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants

100% Center coverage: 2 sources

News about Malvern, Pennsylvania

News about Malvern, Pennsylvania

Local News Publishers

Top Malvern, Pennsylvania News

Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mergers and Acquisitions (M&A): Pinnaql, Inc. Acquires Validation & Engineering Group, Inc.

Mergers and Acquisitions (M&A): Pinnaql, Inc. Acquires Validation & Engineering Group, Inc.

Ocugen Gains EMA Backing for Single Pivotal Trial to Support Stargardt Disease Gene Therapy Approval

Annovis Bio Advances Alzheimer’s Phase 3 Trial, Strengthens IP Portfolio

2X Earns Fifth Inc. 5000 Ranking, Citing Rapid Growth in B2B Marketing Transformation

Vishay Precision Group to Present at Two Upcoming Investor Conferences

TELA Bio Posts Double-Digit Revenue Growth, Expands Product Reach in Q2

Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to ...

Annovis Bio Secures Full Patent Protection for New Crystal Form of Alzheimer’s Drug Buntanetap

Neuronetics Issues Inducement Equity Awards to New Hires

Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants

Local News Publishers

Breaking News Topics Related to Malvern, Pennsylvania

Mergers and Acquisitions (M&A): Pinnaql, Inc. Acquires Validation & Engineering Group, Inc.

Ocugen Gains EMA Backing for Single Pivotal Trial to Support Stargardt Disease Gene Therapy Approval

Annovis Bio Advances Alzheimer’s Phase 3 Trial, Strengthens IP Portfolio

2X Earns Fifth Inc. 5000 Ranking, Citing Rapid Growth in B2B Marketing Transformation

Vishay Precision Group to Present at Two Upcoming Investor Conferences

TELA Bio Posts Double-Digit Revenue Growth, Expands Product Reach in Q2

Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to ...

Annovis Bio Secures Full Patent Protection for New Crystal Form of Alzheimer’s Drug Buntanetap

Neuronetics Issues Inducement Equity Awards to New Hires

Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants